1-3 of 3
Jacques JM van Dongen, Ph.D
Close
Sort by
Journal Articles

Deletion of IKZF1 in Pediatric Precursor-B ALL Is a Strong Prognostic Marker for Relapse.

Roland P. Kuiper, PhD, Esmee Waanders, PhD, Vincent H.J. Van der Velden, PhD, Simon V van Reijmersdal, Blanca Scheijen, PhD, Jayne Hehir-Kwa, Suzanne T.M. Keijzers-Vloet, Edwin Sonneveld, PhD, Jacques JM van Dongen, Ph.D, Frank N. van Leeuwen, PhD, Ad Geurts van Kessel, Peter M. Hoogerbrugge
Journal: Blood
Blood (2009) 114 (22): 1104.
https://doi.org/10.1182/blood.V114.22.1104.1104
Published: 2009
Journal Articles

Ikaros Is a Frequently Affected Hematopoietic Differentiation Factor in Pediatric Relapse-Prone Precursor B-Cell Acute Lymphoblastic Leukemia

Roland P. Kuiper, PhD, Frank N. van Leeuwen, PhD, Vincent van der Velden, Simon V. van Reijmersdal, Jeltje de Vries, PhD, Suzanne T.M. Keijzers-Vloet, Jayne Hehir-Kwa, E. van Wering, Jacques JM van Dongen, Ph.D, Peter M. Hoogerbrugge, Ad Geurts van Kessel
Journal: Blood
Blood (2008) 112 (11): 4144.
https://doi.org/10.1182/blood.V112.11.4144.4144
Published: 2008
Journal Articles

Flow Cytometric Detection of BCR-ABL Fusion Proteins in Leukemia Patients Via An Immunobead Assay

Floor Weerkamp, E. Dekking, Vincent H.J. Van der Velden, Sebastian Böttcher, Nancy Boeckx, Elisabeth R. Van Wering, Juan Flores Montero, Paulo Lucio, Lukasz Sedek, Tomas Kalina, Elizabeth Macintyre, Frank J.T. Staal, Jacques JM van Dongen, Ph.D
Journal: Blood
Blood (2008) 112 (11): 2533.
https://doi.org/10.1182/blood.V112.11.2533.2533
Published: 2008